Publications by authors named "Benjamin A Gartrell"

Claim this Profile
T
Temporal Trends and Socioeconomic Determinants of Cytoreductive Nephrectomy Utilization for Metastatic Renal Cell Carcinoma in the USA.
Stepan M Esagian, Pavlos Msaouel, Jose A Karam, Benjamin A Gartrell, Dimitrios Makrakis

Eur Urol Focus· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonoperative Management of Mismatch Repair-Deficient Tumors.
Christopher D Jakubowski, Amit Verma, Benjamin A Gartrell

N Engl J Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Packing the Punch: Current and Emerging Treatment Strategies in Metastatic Castration-Sensitive Prostate Cancer.
Steven P Troy, Christopher D Jakubowski, Benjamin A Gartrell

Curr Urol Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial.
Daniel Sentana-Lledo, Xiangying Chu, Charles J Ryan, Arjun Gupta, Christopher J Sweeney, Benjamin A Gartrell

Eur Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Presentation of Lichenoid Dermatoses Preceding Bullous Pemphigoid Secondary to Immune Checkpoint Inhibitor Therapy.
Lindsay M Pattison, Bahar Javdan, Pooja Srivastava, Bijal Amin, Benjamin A Gartrell

Skinmed· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influential Factors Impacting Treatment Decision-making and Decision Regret in Patients with Localized or Locally Advanced Prostate Cancer: A Systematic Literature Review.
Benjamin A Gartrell, Angaja Phalguni, Paulina Bajko, Suneel D Mundle, Sharon A McCarthy

Eur Urol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy.
Petros Grivas, Vadim S Koshkin, Xiangying Chu, Suzanne Cole, Rohit K Jain, Benjamin A Gartrell

Eur Urol Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma.
Shuchi Gulati, Pedro C Barata, Andrew Elliott, Mehmet Asim Bilen, Earle F Burgess, Benjamin Adam Gartrell

J Clin Invest· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles.
Pedro Barata, Shuchi Gulati, Andrew Elliott, Hans J Hammers, Earle Burgess, Benjamin A Gartrell

J Clin Invest· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.
John Shen, Simon Chowdhury, Neeraj Agarwal, Lawrence I Karsh, Stéphane Oudard, Benjamin A Gartrell

Br J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Performance and Safety of F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.
Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw Twardowski

J Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Performance and Safety of F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT).
Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw Twardowski

J Urol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw Twardowski

J Urol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer.
Brant A Inman, Noah M Hahn, Kelly Stratton, Ryan Kopp, Alex Sankin, Benjamin A Gartrell

Eur Urol Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Rafee Talukder, Dimitrios Makrakis, Genevieve Ihsiu Lin, Leonidas N Diamantopoulos, Scott Dawsey, Benjamin A Gartrell

Clin Genitourin Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
Dimitrios Makrakis, Rafee Talukder, Leonidas N Diamantopoulos, Lucia Carril-Ajuria, Daniel Castellano, Benjamin A Gartrell

BJU Int· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Dimitrios Makrakis, Rafee Talukder, Genevieve Ihsiu Lin, Leonidas N Diamantopoulos, Scott Dawsey, Benjamin A Gartrell

Clin Genitourin Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial.
Chung-Han Lee, Robert Motzer, Hamid Emamekhoo, Marc Matrana, Ivor Percent, Benjamin A Gartrell

Clin Cancer Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer.
Neil J Shah, Vaibhav G Patel, Xiaobo Zhong, Luis Pina, Jessica E Hawley, Benjamin A Gartrell

JNCI Cancer Spectr· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Rafee Talukder, Dimitrios Makrakis, Leonidas N Diamantopoulos, Lucia Carril-Ajuria, Daniel Castellano, Benjamin A Gartrell

Clin Genitourin Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience.
Brian A Costello, Nrupen A Bhavsar, Yousef Zakharia, Sumanta K Pal, Ulka Vaishampayan, Benjamin A Gartrell

Clin Genitourin Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant use of oral anticoagulants in patients with advanced prostate cancer receiving apalutamide: A post-hoc analysis of TITAN and SPARTAN studies.
Rushikesh Potdar, Benjamin A Gartrell, Robert Given, Lawrence Karsh, Jeffrey Frankel

Am J Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19.
Andrew L Schmidt, Matthew D Tucker, Ziad Bakouny, Chris Labaki, Chih-Yuan Hsu, Benjamin A Gartrell

JAMA Netw Open· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer.
Ritesh K Aggarwal, Rebecca A Luchtel, Venkata Machha, Alexander Tischer, Yiyu Zou, Benjamin A Gartrell

Proc Natl Acad Sci U S A· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC).
Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, Ulka Vaishampayan, Sumanta K Pal, Benjamin A Gartrell

Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis